Industry Research Reports
Home > Reports > Chemical & Material > Global Taurine and Derivatives Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Taurine and Derivatives Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-09-08
Pages: 134 Pages
Report ld: 4849926
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Taurine and Derivatives market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic naturally occurred amino sulfonic acid that is widely distributed in animal tissues.[1] It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.
From a downstream perspective, Food and Beverages accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Taurine and Derivatives leading manufacturers including Yongan Pharmaceutical, Grand Pharma, Jiangyin Huachang, Yuanyang Pharmaceutical, Taisho Pharmaceutical, Zhejiang NHU Co., Ltd, Shengyuan Environmental Protection, etc., dominate supply; the top five capture approximately % of global revenue, with Yongan Pharmaceutical leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Taurine and Derivatives market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Yongan Pharmaceutical
- Grand Pharma
- Jiangyin Huachang
- Yuanyang Pharmaceutical
- Taisho Pharmaceutical
- Zhejiang NHU Co., Ltd
- Shengyuan Environmental Protection
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Taurine
- Taurine Derivatives
Segment by Application
- Food and Beverages
- Medicine and Health Products
- Feed
- Pet Food
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Taurine and Derivatives study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Taurine and Derivatives: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Taurine and Derivatives Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Taurine
1.2.3 Taurine Derivatives
1.3 Market Segmentation by Application
1.3.1 Global Taurine and Derivatives Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food and Beverages
1.3.3 Medicine and Health Products
1.3.4 Feed
1.3.5 Pet Food
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Taurine and Derivatives Revenue Estimates and Forecasts 2020-2031
2.2 Global Taurine and Derivatives Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Taurine and Derivatives Sales Estimates and Forecasts 2020-2031
2.4 Global Taurine and Derivatives Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Taurine and Derivatives Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 China
4 Competition by Manufacturers
4.1 Global Taurine and Derivatives Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Taurine and Derivatives Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Taurine Market Size by Manufacturers
4.5.2 Taurine Derivatives Market Size by Manufacturers
4.6 Global Taurine and Derivatives Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Taurine and Derivatives Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Taurine and Derivatives Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Taurine and Derivatives Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Taurine and Derivatives Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Taurine and Derivatives Sales and Revenue by Type (2020-2031)
7.4 North America Taurine and Derivatives Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Taurine and Derivatives Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Taurine and Derivatives Sales and Revenue by Type (2020-2031)
8.4 Europe Taurine and Derivatives Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Taurine and Derivatives Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Taurine and Derivatives Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Taurine and Derivatives Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Taurine and Derivatives Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Taurine and Derivatives Sales and Revenue by Type (2020-2031)
10.4 Central and South America Taurine and Derivatives Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Taurine and Derivatives Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Taurine and Derivatives Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Taurine and Derivatives Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Taurine and Derivatives Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Yongan Pharmaceutical
12.1.1 Yongan Pharmaceutical Corporation Information
12.1.2 Yongan Pharmaceutical Business Overview
12.1.3 Yongan Pharmaceutical Taurine and Derivatives Product Models, Descriptions and Specifications
12.1.4 Yongan Pharmaceutical Taurine and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Yongan Pharmaceutical Taurine and Derivatives Sales by Product in 2024
12.1.6 Yongan Pharmaceutical Taurine and Derivatives Sales by Application in 2024
12.1.7 Yongan Pharmaceutical Taurine and Derivatives Sales by Geographic Area in 2024
12.1.8 Yongan Pharmaceutical Taurine and Derivatives SWOT Analysis
12.1.9 Yongan Pharmaceutical Recent Developments
12.2 Grand Pharma
12.2.1 Grand Pharma Corporation Information
12.2.2 Grand Pharma Business Overview
12.2.3 Grand Pharma Taurine and Derivatives Product Models, Descriptions and Specifications
12.2.4 Grand Pharma Taurine and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Grand Pharma Taurine and Derivatives Sales by Product in 2024
12.2.6 Grand Pharma Taurine and Derivatives Sales by Application in 2024
12.2.7 Grand Pharma Taurine and Derivatives Sales by Geographic Area in 2024
12.2.8 Grand Pharma Taurine and Derivatives SWOT Analysis
12.2.9 Grand Pharma Recent Developments
12.3 Jiangyin Huachang
12.3.1 Jiangyin Huachang Corporation Information
12.3.2 Jiangyin Huachang Business Overview
12.3.3 Jiangyin Huachang Taurine and Derivatives Product Models, Descriptions and Specifications
12.3.4 Jiangyin Huachang Taurine and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Jiangyin Huachang Taurine and Derivatives Sales by Product in 2024
12.3.6 Jiangyin Huachang Taurine and Derivatives Sales by Application in 2024
12.3.7 Jiangyin Huachang Taurine and Derivatives Sales by Geographic Area in 2024
12.3.8 Jiangyin Huachang Taurine and Derivatives SWOT Analysis
12.3.9 Jiangyin Huachang Recent Developments
12.4 Yuanyang Pharmaceutical
12.4.1 Yuanyang Pharmaceutical Corporation Information
12.4.2 Yuanyang Pharmaceutical Business Overview
12.4.3 Yuanyang Pharmaceutical Taurine and Derivatives Product Models, Descriptions and Specifications
12.4.4 Yuanyang Pharmaceutical Taurine and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Yuanyang Pharmaceutical Taurine and Derivatives Sales by Product in 2024
12.4.6 Yuanyang Pharmaceutical Taurine and Derivatives Sales by Application in 2024
12.4.7 Yuanyang Pharmaceutical Taurine and Derivatives Sales by Geographic Area in 2024
12.4.8 Yuanyang Pharmaceutical Taurine and Derivatives SWOT Analysis
12.4.9 Yuanyang Pharmaceutical Recent Developments
12.5 Taisho Pharmaceutical
12.5.1 Taisho Pharmaceutical Corporation Information
12.5.2 Taisho Pharmaceutical Business Overview
12.5.3 Taisho Pharmaceutical Taurine and Derivatives Product Models, Descriptions and Specifications
12.5.4 Taisho Pharmaceutical Taurine and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Taisho Pharmaceutical Taurine and Derivatives Sales by Product in 2024
12.5.6 Taisho Pharmaceutical Taurine and Derivatives Sales by Application in 2024
12.5.7 Taisho Pharmaceutical Taurine and Derivatives Sales by Geographic Area in 2024
12.5.8 Taisho Pharmaceutical Taurine and Derivatives SWOT Analysis
12.5.9 Taisho Pharmaceutical Recent Developments
12.6 Zhejiang NHU Co., Ltd
12.6.1 Zhejiang NHU Co., Ltd Corporation Information
12.6.2 Zhejiang NHU Co., Ltd Business Overview
12.6.3 Zhejiang NHU Co., Ltd Taurine and Derivatives Product Models, Descriptions and Specifications
12.6.4 Zhejiang NHU Co., Ltd Taurine and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Zhejiang NHU Co., Ltd Recent Developments
12.7 Shengyuan Environmental Protection
12.7.1 Shengyuan Environmental Protection Corporation Information
12.7.2 Shengyuan Environmental Protection Business Overview
12.7.3 Shengyuan Environmental Protection Taurine and Derivatives Product Models, Descriptions and Specifications
12.7.4 Shengyuan Environmental Protection Taurine and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Shengyuan Environmental Protection Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Taurine and Derivatives Industry Chain
13.2 Taurine and Derivatives Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Taurine and Derivatives Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Taurine and Derivatives Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Taurine and Derivatives Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Taurine and Derivatives Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Taurine and Derivatives Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Taurine and Derivatives Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Taurine and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Taurine and Derivatives Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Taurine and Derivatives Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Taurine and Derivatives Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Taurine and Derivatives Sales by Region (2020-2025) & (Tons)
Table 8. Global Taurine and Derivatives Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Taurine and Derivatives Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Taurine and Derivatives Production by Region (2020-2025) & (Tons)
Table 12. Global Taurine and Derivatives Production by Region (2026-2031) & (Tons)
Table 13. Global Taurine and Derivatives Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Taurine and Derivatives Sales Share by Manufacturers (2020-2025)
Table 15. Global Taurine and Derivatives Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Taurine and Derivatives Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Taurine and Derivatives by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Taurine and Derivatives as of 2024)
Table 19. Global Taurine and Derivatives Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Taurine and Derivatives Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Taurine and Derivatives Manufacturing Base and Headquarters
Table 22. Global Taurine and Derivatives Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Taurine and Derivatives Sales by Type (2020-2025) & (Tons)
Table 26. Global Taurine and Derivatives Sales by Type (2026-2031) & (Tons)
Table 27. Global Taurine and Derivatives Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Taurine and Derivatives Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Taurine and Derivatives ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Taurine and Derivatives Sales by Application (2020-2025) & (Tons)
Table 32. Global Taurine and Derivatives Sales by Application (2026-2031) & (Tons)
Table 33. Taurine and Derivatives High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Taurine and Derivatives Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Taurine and Derivatives Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Taurine and Derivatives ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Taurine and Derivatives Growth Accelerators and Market Barriers
Table 40. North America Taurine and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Taurine and Derivatives Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Taurine and Derivatives Growth Accelerators and Market Barriers
Table 43. Europe Taurine and Derivatives Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Taurine and Derivatives Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Taurine and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Taurine and Derivatives Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Taurine and Derivatives Growth Accelerators and Market Barriers
Table 48. Southeast Asia Taurine and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Taurine and Derivatives Investment Opportunities and Key Challenges
Table 50. Central and South America Taurine and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Taurine and Derivatives Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Taurine and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Yongan Pharmaceutical Corporation Information
Table 54. Yongan Pharmaceutical Description and Major Businesses
Table 55. Yongan Pharmaceutical Product Models, Descriptions and Specifications
Table 56. Yongan Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Yongan Pharmaceutical Sales Value Proportion by Product in 2024
Table 58. Yongan Pharmaceutical Sales Value Proportion by Application in 2024
Table 59. Yongan Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 60. Yongan Pharmaceutical Taurine and Derivatives SWOT Analysis
Table 61. Yongan Pharmaceutical Recent Developments
Table 62. Grand Pharma Corporation Information
Table 63. Grand Pharma Description and Major Businesses
Table 64. Grand Pharma Product Models, Descriptions and Specifications
Table 65. Grand Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Grand Pharma Sales Value Proportion by Product in 2024
Table 67. Grand Pharma Sales Value Proportion by Application in 2024
Table 68. Grand Pharma Sales Value Proportion by Geographic Area in 2024
Table 69. Grand Pharma Taurine and Derivatives SWOT Analysis
Table 70. Grand Pharma Recent Developments
Table 71. Jiangyin Huachang Corporation Information
Table 72. Jiangyin Huachang Description and Major Businesses
Table 73. Jiangyin Huachang Product Models, Descriptions and Specifications
Table 74. Jiangyin Huachang Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Jiangyin Huachang Sales Value Proportion by Product in 2024
Table 76. Jiangyin Huachang Sales Value Proportion by Application in 2024
Table 77. Jiangyin Huachang Sales Value Proportion by Geographic Area in 2024
Table 78. Jiangyin Huachang Taurine and Derivatives SWOT Analysis
Table 79. Jiangyin Huachang Recent Developments
Table 80. Yuanyang Pharmaceutical Corporation Information
Table 81. Yuanyang Pharmaceutical Description and Major Businesses
Table 82. Yuanyang Pharmaceutical Product Models, Descriptions and Specifications
Table 83. Yuanyang Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Yuanyang Pharmaceutical Sales Value Proportion by Product in 2024
Table 85. Yuanyang Pharmaceutical Sales Value Proportion by Application in 2024
Table 86. Yuanyang Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 87. Yuanyang Pharmaceutical Taurine and Derivatives SWOT Analysis
Table 88. Yuanyang Pharmaceutical Recent Developments
Table 89. Taisho Pharmaceutical Corporation Information
Table 90. Taisho Pharmaceutical Description and Major Businesses
Table 91. Taisho Pharmaceutical Product Models, Descriptions and Specifications
Table 92. Taisho Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Taisho Pharmaceutical Sales Value Proportion by Product in 2024
Table 94. Taisho Pharmaceutical Sales Value Proportion by Application in 2024
Table 95. Taisho Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 96. Taisho Pharmaceutical Taurine and Derivatives SWOT Analysis
Table 97. Taisho Pharmaceutical Recent Developments
Table 98. Zhejiang NHU Co., Ltd Corporation Information
Table 99. Zhejiang NHU Co., Ltd Description and Major Businesses
Table 100. Zhejiang NHU Co., Ltd Product Models, Descriptions and Specifications
Table 101. Zhejiang NHU Co., Ltd Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Zhejiang NHU Co., Ltd Recent Developments
Table 103. Shengyuan Environmental Protection Corporation Information
Table 104. Shengyuan Environmental Protection Description and Major Businesses
Table 105. Shengyuan Environmental Protection Product Models, Descriptions and Specifications
Table 106. Shengyuan Environmental Protection Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Shengyuan Environmental Protection Recent Developments
Table 108. Key Raw Materials Distribution
Table 109. Raw Materials Key Suppliers
Table 110. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 111. Milestones in Production Technology Evolution
Table 112. Distributors List
Table 113. Market Trends and Market Evolution
Table 114. Market Drivers and Opportunities
Table 115. Market Challenges, Risks, and Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Taurine and Derivatives Product Picture
Figure 2. Global Taurine and Derivatives Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Taurine Product Picture
Figure 4. Taurine Derivatives Product Picture
Figure 5. Global Taurine and Derivatives Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Food and Beverages
Figure 7. Medicine and Health Products
Figure 8. Feed
Figure 9. Pet Food
Figure 10. Others
Figure 11. Taurine and Derivatives Report Years Considered
Figure 12. Global Taurine and Derivatives Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 14. Global Taurine and Derivatives Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Taurine and Derivatives Revenue Market Share by Region (2020-2031)
Figure 16. Global Taurine and Derivatives Sales (2020-2031) & (Tons)
Figure 17. Global Taurine and Derivatives Sales (CAGR) by Region (2020-2031) (Tons)
Figure 18. Global Taurine and Derivatives Sales Market Share by Region (2020-2031)
Figure 19. Global Taurine and Derivatives Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 20. Global Taurine and Derivatives Production Trend by Region (2020-2031) (Tons)
Figure 21. Global Taurine and Derivatives Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Taurine and Derivatives Production Growth Rate in China (2020-2031) & (Tons)
Figure 24. Top 5 and Top 10 Manufacturers Taurine and Derivatives Sales Volume Market Share in 2024
Figure 25. Global Taurine and Derivatives Revenue Market Share Ranking (2024)
Figure 26. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 27. Taurine Revenue Market Share by Manufacturer in 2024
Figure 28. Taurine Derivatives Revenue Market Share by Manufacturer in 2024
Figure 29. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 30. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 31. Global Taurine and Derivatives Sales Market Share by Type (2020-2031)
Figure 32. Global Taurine and Derivatives Revenue Market Share by Type (2020-2031)
Figure 33. Global Taurine and Derivatives Sales Market Share by Application (2020-2031)
Figure 34. Global Taurine and Derivatives Revenue Market Share by Application (2020-2031)
Figure 35. North America Taurine and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 36. North America Taurine and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 37. North America Top 5 Manufacturers Taurine and Derivatives Sales Revenue (US$ Million) in 2024
Figure 38. North America Taurine and Derivatives Sales Volume (Tons) by Type (2020- 2031)
Figure 39. North America Taurine and Derivatives Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 40. North America Taurine and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 41. North America Taurine and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. US Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 43. Canada Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 44. Mexico Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 45. Europe Taurine and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 46. Europe Taurine and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 47. Europe Top 5 Manufacturers Taurine and Derivatives Sales Revenue (US$ Million) in 2024
Figure 48. Europe Taurine and Derivatives Sales Volume (Tons) by Type (2020-2031)
Figure 49. Europe Taurine and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 50. Europe Taurine and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 51. Europe Taurine and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 52. Germany Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 53. France Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 54. U.K. Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 55. Italy Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 56. Russia Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific Taurine and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 58. Asia-Pacific Taurine and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Top 8 Manufacturers Taurine and Derivatives Sales Revenue (US$ Million) in 2024
Figure 60. Asia-Pacific Taurine and Derivatives Sales Volume (Tons) by Type (2020- 2031)
Figure 61. Asia-Pacific Taurine and Derivatives Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 62. Asia-Pacific Taurine and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 63. Asia-Pacific Taurine and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 64. Indonesia Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 65. Japan Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 66. South Korea Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 67. China Taiwan Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 68. India Taurine and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 69. Central and South America Taurine and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 70. Central and South America Taurine and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Central and South America Top 5 Manufacturers Taurine and Derivatives Sales Revenue (US$ Million) in 2024
Figure 72. Central and South America Taurine and Derivatives Sales Volume (Tons) by Type (2021-2031)
Figure 73. Central and South America Taurine and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Central and South America Taurine and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 75. Central and South America Taurine and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. Brazil Taurine and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 77. Argentina Taurine and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 78. Middle East, and Africa Taurine and Derivatives Sales YoY (2020-2031) & (Tons)
Figure 79. Middle East and Africa Taurine and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 80. Middle East and Africa Top 5 Manufacturers Taurine and Derivatives Sales Revenue (US$ Million) in 2024
Figure 81. Middle East and Africa Taurine and Derivatives Sales Volume (Tons) by Type (2021-2031)
Figure 82. South America Taurine and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 83. Middle East and Africa Taurine and Derivatives Sales Volume (Tons) by Application (2020-2031)
Figure 84. Middle East and Africa Taurine and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 85. GCC Countries Taurine and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 86. Turkey Taurine and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 87. Egypt Taurine and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 88. South Africa Taurine and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 89. Taurine and Derivatives Industry Chain Mapping
Figure 90. Regional Taurine and Derivatives Manufacturing Base Distribution (%)
Figure 91. Taurine and Derivatives Production Process
Figure 92. Regional Taurine and Derivatives Production Cost Structure
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Taurine and Derivatives market?
The top companies in the global Taurine and Derivatives market are Yongan Pharmaceutical、Grand Pharma、Jiangyin Huachang.
Related Reports
Global Taurine and Derivatives Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Taurine and Derivatives market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 138
USD 4900.00
(Single User License)
Global Taurine and Derivatives Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Taurine and Derivatives market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 76
USD 4250.00
(Single User License)
Taurine and Derivatives- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Taurine and Derivatives was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 97
USD 3950.00
(Single User License)
Global Taurine and Derivatives Market Research Report 2026
The global Taurine and Derivatives market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 131
USD 2900.00
(Single User License)
Global Taurine and Derivatives Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Taurine and Derivatives market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-08
Pages: 76
USD 4250.00
(Single User License)
Taurine and Derivatives - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Taurine and Derivatives was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-08
Pages: 100
USD 3950.00
(Single User License)
Global Taurine and Derivatives Market Research Report 2025
The global market for Taurine and Derivatives was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-09-08
Pages: 95
USD 2900.00
(Single User License)
Global Taurine and Derivatives Market Research Report 2024
Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic naturally occurred amino sulfonic acid that is widely distributed in animal tissues.[1] It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.
Published Date: 2024-10-16
Pages: 92
USD 2900.00
(Single User License)
Global and China Taurine and Derivatives Market Report & Forecast 2024-2030
Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic naturally occurred amino sulfonic acid that is widely distributed in animal tissues.[1] It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.
Published Date: 2024-10-16
Pages: 115
USD 4350.00
(Single User License)
Global Taurine and Derivatives Market Insights, Forecast to 2030
Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic naturally occurred amino sulfonic acid that is widely distributed in animal tissues.[1] It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.
Published Date: 2024-10-16
Pages: 135
USD 4900.00
(Single User License)
Global Taurine and Derivatives Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Taurine and Derivatives market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 138
USD 4900.00 (Single User License)Global Taurine and Derivatives Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Taurine and Derivatives market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 76
USD 4250.00 (Single User License)Taurine and Derivatives- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Taurine and Derivatives was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 97
USD 3950.00 (Single User License)Global Taurine and Derivatives Market Research Report 2026
The global Taurine and Derivatives market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 131
USD 2900.00 (Single User License)Global Taurine and Derivatives Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Taurine and Derivatives market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-08
Pages: 76
USD 4250.00 (Single User License)Taurine and Derivatives - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Taurine and Derivatives was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-08
Pages: 100
USD 3950.00 (Single User License)Global Taurine and Derivatives Market Research Report 2025
The global market for Taurine and Derivatives was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-09-08
Pages: 95
USD 2900.00 (Single User License)Global Taurine and Derivatives Market Research Report 2024
Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic naturally occurred amino sulfonic acid that is widely distributed in animal tissues.[1] It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.
Published: 2024-10-16
Pages: 92
USD 2900.00 (Single User License)Global and China Taurine and Derivatives Market Report & Forecast 2024-2030
Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic naturally occurred amino sulfonic acid that is widely distributed in animal tissues.[1] It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.
Published: 2024-10-16
Pages: 115
USD 4350.00 (Single User License)Global Taurine and Derivatives Market Insights, Forecast to 2030
Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic naturally occurred amino sulfonic acid that is widely distributed in animal tissues.[1] It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.
Published: 2024-10-16
Pages: 135
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now